| ADE (Incidence %) | Antineoplastons | Vredenburgh et al. [25] | Reardon et al. [26] | Desjardins et al. [27] | Omuro et al. [20] |
| Treatment related death | 9 | 3 | |||
| Hypokalemia | 7.5 | 3 | |||
| Hypernatremia | 12.5 | ||||
| Hyponatremia | 1 | 5 | |||
| Dehydration | 1 | 3 | |||
| Fatigue | 5 | 9 | 4 | 9 | 5 |
| Thrombocytopenia | 13 | 3 | |||
| Neutropenia | 17 | ||||
| Lymphopenia | 30 | ||||
| Anemia | 3 | ||||
| Dyspnea | 3 | ||||
| Diarrhea | 3 | ||||
| Somnolence | 2.5 | ||||
| Vomiting | 1 | ||||
| Colitis | 3 | ||||
| Pancreatitis | 3 | ||||
| Anal fissure | 4 | ||||
| Hemorrhoids | 3 | ||||
| Transaminase elevation | 1 | 5 | |||
| Stomatitis | 1 | ||||
| Thromboembolic event | 17 | 1 | 3 | ||
| Neuropathy | 3 | ||||
| Allergic reaction | 4 | ||||
| Infection | 3 | ||||
| Hypophosphatemia | 1 |